Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Akebia Therapeutics Inc (NASDAQ:AKBA)

9.11
Delayed Data
As of Mar 24
 +0.01 / +0.11%
Today’s Change
7.00
Today|||52-Week Range
11.07
-12.49%
Year-to-Date
No recent news for Akebia Therapeutics Inc.

Today’s Trading

Previous close9.10
Today’s open9.14
Day’s range9.05 - 9.38
Volume162,077
Average volume (3 months)259,383
Market cap$353.7M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-57.21%
Earnings growth (this year)+30.41%
Earnings growth (next 5 years)+15.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales255.79
Price/Book5.16

Competitors

 Today’s
change
Today’s
% change
CCXIChemoCentryx Inc+0.32+4.52%
ARNAArena Pharmaceutical...+0.01+0.69%
AQXPAquinox Pharmaceutic...+0.12+0.79%
OMEDOncoMed Pharmaceutic...+0.03+0.33%
Data as of 4:14pm ET, 03/24/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$1.5M
Annual profit (last year)-$135.7M
Net profit margin-8,843.45%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class III Director
John P. Butler
CFO, Treasure, SVP &
Principal Accounting Officer
Jason A. Amello
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs